HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tamihiro Kawakami Selected Research

Histones (Histone)

12/2022Typical cutaneous small-vessel vasculitis induced by combined injection of antiphosphatidylserine/prothrombin complex antibody and anti-LAMP-2 antibody in normal rats.
7/2022Presence of neutrophil extracellular traps in superficial venous thrombosis of Behçet's disease.
5/2021Anti-phosphatidylserine/prothrombin complex antibodies in patients with cutaneous vasculitis: Possible involvement in the pathogenesis.
3/2020Relationship between lysosomal-associated membrane protein-2 and anti-phosphatidylserine/prothrombin complex antibody in the pathogenesis of cutaneous vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tamihiro Kawakami Research Topics

Disease

16Vasculitis (Vasculitides)
01/2023 - 06/2007
10Polyarteritis Nodosa (Periarteritis Nodosa)
07/2017 - 12/2007
8Vascular Skin Diseases
12/2022 - 05/2009
8Microscopic Polyangiitis
01/2016 - 01/2006
7Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2022 - 01/2006
7Atopic Dermatitis (Atopic Eczema)
09/2014 - 10/2003
6Pemphigus (Pemphigus Vulgaris)
01/2018 - 07/2012
6Purpura
08/2011 - 06/2007
5Churg-Strauss Syndrome (Allergic Angiitis)
04/2021 - 06/2007
5Pruritus (Itching)
06/2012 - 10/2003
4Arteritis
12/2022 - 12/2013
4IgA Vasculitis (Purpura, Schoenlein Henoch)
12/2022 - 02/2010
3Vitiligo
11/2022 - 09/2002
3Melanoma (Melanoma, Malignant)
04/2022 - 01/2016
3Systemic Vasculitis
10/2021 - 01/2013
3Bullous Pemphigoid (Pemphigoid)
01/2021 - 03/2009
3Erythema elevatum diutinum
09/2011 - 02/2010
3Livedo Reticularis
03/2011 - 06/2007
3Behcet Syndrome (Behcet's Syndrome)
02/2009 - 11/2003
2Drug Hypersensitivity Syndrome
12/2022 - 01/2009
2Thrombophlebitis
07/2022 - 02/2009
2Disseminated Intravascular Coagulation
07/2022 - 04/2019
2Ulcer
09/2021 - 09/2015
2Mononeuropathies (Mononeuritis Multiplex)
04/2021 - 12/2013
2Neoplasms (Cancer)
10/2017 - 05/2009
2Thrombosis (Thrombus)
01/2017 - 06/2007
2Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2016 - 02/2010
2Asthma (Bronchial Asthma)
07/2013 - 07/2005
2Eosinophilia
07/2013 - 01/2009
2Nephritis
12/2010 - 02/2010
2Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)
02/2010 - 04/2008
2Hypersensitivity (Allergy)
05/2009 - 01/2009
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
12/2007 - 12/2005
1Acute Generalized Exanthematous Pustulosis
12/2022
1Macrophage Activation Syndrome
07/2022
1Erythema Nodosum
07/2022
1Blister (Bulla)
04/2022
1Hematuria
01/2022
1Heart Failure
04/2021

Drug/Important Bio-Agent (IBA)

15AntibodiesIBA
09/2021 - 12/2007
14Prothrombin (Factor II)IBA
12/2022 - 12/2007
11PhosphatidylserinesIBA
09/2021 - 12/2007
10Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2023 - 01/2006
10Immunoglobulin M (IgM)IBA
09/2021 - 12/2007
8AutoantibodiesIBA
01/2018 - 12/2005
7Adrenal Cortex Hormones (Corticosteroids)IBA
04/2021 - 02/2010
7mizoribineIBA
07/2012 - 03/2009
7Antiphospholipid AntibodiesIBA
08/2011 - 06/2007
5Antigen-Antibody Complex (Immune Complex)IBA
01/2023 - 06/2007
5Proteins (Proteins, Gene)FDA Link
12/2022 - 12/2005
5Peroxidase (Myeloperoxidase)IBA
07/2022 - 01/2006
5Immunoglobulin A (IgA)IBA
01/2022 - 04/2008
5Immunoglobulin G (IgG)IBA
05/2021 - 12/2007
5Therapeutic UsesIBA
09/2015 - 08/2008
5Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
08/2011 - 12/2007
4Histones (Histone)IBA
12/2022 - 03/2020
3Messenger RNA (mRNA)IBA
12/2022 - 11/2014
3AntigensIBA
12/2022 - 01/2013
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2021 - 02/2014
3Intravenous Immunoglobulins (IVIG)FDA Link
04/2021 - 01/2009
3Prednisolone (Predate)FDA LinkGeneric
12/2013 - 03/2011
3Histamine Antagonists (Antihistamines)IBA
07/2012 - 10/2003
3Warfarin (Coumadin)FDA LinkGeneric
03/2011 - 02/2010
2Cadherins (E-Cadherin)IBA
04/2022 - 07/2013
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 05/2009
2C-Reactive ProteinIBA
10/2021 - 12/2013
2Immunoglobulins (Immunoglobulin)IBA
05/2021 - 11/2013
2AutoantigensIBA
01/2021 - 02/2016
2moesinIBA
07/2017 - 01/2017
2Biomarkers (Surrogate Marker)IBA
01/2016 - 09/2014
2ImmunosorbentsIBA
01/2016 - 11/2013
2EnzymesIBA
01/2016 - 11/2013
2Interleukin-6 (Interleukin 6)IBA
05/2012 - 09/2009
2EmollientsIBA
05/2012 - 06/2011
2Clopidogrel (Plavix)FDA Link
02/2010 - 01/2010
2Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA
08/2006 - 10/2003
2Histamine (Histamine Dihydrochloride)FDA Link
08/2006 - 10/2003
2Tryptases (Tryptase)IBA
08/2006 - 10/2003
12019-nCoV Vaccine mRNA-1273IBA
12/2022
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2022
1Dacarbazine (DIC)FDA LinkGeneric
07/2022
1IgA receptor (protein B)IBA
04/2022
1Protein Kinase InhibitorsIBA
04/2022
1Discoidin Domain Receptor 1IBA
04/2022
1Oxidoreductases (Dehydrogenase)IBA
04/2022
1Glycoproteins (Glycoprotein)IBA
04/2022
1Immune Checkpoint ProteinsIBA
10/2021
1B7-H1 AntigenIBA
10/2021
1Programmed Cell Death 1 ReceptorIBA
10/2021
1mepolizumabIBA
04/2021
1Immunologic Factors (Immunomodulators)IBA
04/2021
1Laminin (Merosin)IBA
01/2021
1Matrix Metalloproteinases (MMPs)IBA
01/2021
1KalininIBA
01/2021

Therapy/Procedure

22Therapeutics
04/2022 - 10/2003
2Intravenous Injections
12/2022 - 01/2017
1Intravenous Administration
12/2022
1Tissue Transplantation
04/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
04/2022
1Operative Surgical Procedures
04/2022